Budd-Chiari Syndrome and Portal Vein Thrombosis: Etiology and Treatment
(Etiologie en behandeling van het Budd-Chiari syndroom en vena portae trombose)
2012-01-12
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(120112_Smalberg, Jasper Hoite - bewerkt.pdf, 3.4MB) |
|
View PDF Version
(stellingen Smalberg.pdf, 0.0MB) |
Venous thrombosis is a common disorder with an annual incidence of around 1-2 cases per 1.000 individuals and is the third leading cause of cardiovascular morbidity and mortality in developed countries.1-4 Thrombosis may arise in any section of the venous system, but it typically occurs in the deep veins of the lower extremities. The major concern in these patients is pulmonary embolism, which can be fatal. A more common, but often disabling, complication of deep vein thrombosis and its sequelae is the post-thrombotic syndrome.5 Rarely, thrombosis may involve other venous sites. One of these uncommon manifestations of thrombosis is located in the splanchnic veins, which is accompanied by a considerable morbidity and mortality.
J.E. Jurriaanse Stichting
Pfizer
Novartis
Bayer
Dutch Heart Foundation
Alexon
Celgene
Fonds Wetenschappelijk Onderzoek van de MPN Stichting
Shire
- patient
- thrombosis
- study
- factor
- portal vein thrombosis
- jak 2v
- venou
- budd-chiari syndrome
- portal
- venous thrombosis
- mutation
- fibrinogen
- jak 2v mutation
- chapter
- syndrome
- blood
- pvt patients
- risk factors
- level
- budd-chiari
